CoChat

Risperidone-Related Improvement of Irritability in Children with Autism Is not Associated with Changes in Serum of Epidermal Growth Factor and Interleukin-13

Open access
Tobiasova, Zuzana, van der Lingen, Klaas H. B., Scahill, Lawrence, Leckman, James F., Zhang, Yan, Chae, Wookjin, McCracken, James T., McDougle, Christopher J., Vitiello, Benedetto, Tierney, Elaine, Aman, Michael G., Arnold, L. Eugene, Katsovich, Liliya, Hoekstra, Pieter J., Volkmar, Fred, Bothwell, Alfred L. M., Kawikova, Ivana · 2011 · Journal of Child and Adolescent Psychopharmacology
Cited by 29

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Risperidone has been shown to improve serious behavioral problems in children with autism. Here we asked whether risperidone-associated improvement was related to changes in concentrations of inflammatory molecules in the serum of these subjects. Seven molecules were identified as worthy of further assessment by performing a pilot analysis of 31 inflammatory markers in 21 medication-free subjects with autism versus 15 healthy controls: epidermal growth factor (EGF), interferon-γ (IFN-γ), interleukin (IL)-13, IL-17, monocyte chemoattractant protein-1 (MCP-1), IL-1 and IL-1-receptor antagonist. Serum concentrations of these markers were then established in a different set of subjects that participated in a double-blind, clinical trial and an expanded group of healthy subjects. In the first analysis, samples obtained from subjects with autism at baseline visits were compared to visits after 8-week treatment with placebo (n=37) or risperidone (n=40). The cytokine concentrations remained stable over the 8-week period for both risperidone and placebo groups. In the second analysis, we explored further the differences between medication-free subjects with autism (n=77) and healthy controls (recruited independently; n=19). Serum levels of EGF were elevated in subjects with autism (median=103 pg/mL, n=75) in comparison to healthy controls (75 pg/mL, n=19; p<0.05), and levels of IL-13 were decreased in autism (median=0.8 pg/mL, n=77) in comparison to controls (9.8 pg/mL, n=19; p=0.0003). These changes did not correlate with standardized measures used for a diagnosis of autism. In summary, risperidone-induced clinical improvement in subjects with autism was not associated with changes in the serum inflammatory markers measured. Whether altered levels of EGF and IL-13 play a role in the pathogenesis or phenotype of autism requires further investigation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/cap.2010.0134

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 29

Metadata

Authors
Tobiasova, Z., van der Lingen, K. H. B., Scahill, L., Leckman, J. F., Zhang, Y., Chae, W., McCracken, J. T., McDougle, C. J., Vitiello, B., Tierney, E., Aman, M. G., Arnold, L. E., Katsovich, L., Hoekstra, P. J., Volkmar, F., Bothwell, A. L. M., & Kawikova, I.
Venue
Journal of Child and Adolescent Psychopharmacology
Published
2011-12
Volume
21
Issue
6
Pages
555-564
ISSN
  • 1044-5463 (ISSN-L)
  • 1557-8992
OpenAlex
W2061459077
Cited by
29
References
24
FWCI
0.75
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Risperidone-Related Improvement of Irritability in Children with Autism Is not Associated with Changes in Serum of Epidermal Growth Factor and Interleukin-13. https://app.cochat.ai/papers/10.1089/cap.2010.0134
The paper
Tobiasova, Z., van der Lingen, K. H. B., Scahill, L., Leckman, J. F., Zhang, Y., Chae, W., McCracken, J. T., McDougle, C. J., Vitiello, B., Tierney, E., Aman, M. G., Arnold, L. E., Katsovich, L., Hoekstra, P. J., Volkmar, F., Bothwell, A. L. M., & Kawikova, I. (2011). Risperidone-Related Improvement of Irritability in Children with Autism Is not Associated with Changes in Serum of Epidermal Growth Factor and Interleukin-13. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2010.0134

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.